About SeneSIQ

What SeneSIQ is

SeneSIQ is a reference site built around a mechanism–intervention–study graph for cellular senescence and the drugs that target it. It is deliberately narrow: a small number of landmark interventions and studies, each fully sourced and honestly qualified, rather than a broad advice article. It distinguishes senolytics from senomorphics and reports what each study measured and in which species.

The central honesty fact

No senolytic or senomorphic has a human lifespan or clinical-outcome randomized controlled trial. Lifespan-extension evidence is animal-only (and, for the strongest causal result, a genetic mouse tool, not a drug). Every intervention page carries an evidence flag that reflects this, and no page claims a human longevity effect.

Publisher / editorial identity

Nabus Research is the editorial owner and publisher. This site does not attribute content to any named individual author or reviewer; no person is fabricated for E-E-A-T purposes. When a named, verifiable human reviewer is assigned to a page in a future revision, that attribution will be added — and not before.

Editorial review process

Every intervention page on this site (schema.org MedicalWebPage) carries a visible “Reviewed by Nabus Research” byline with a lastReviewed date, matched by reviewedBy/lastReviewed structured data. This is an organizational editorial review — each page is checked against its data record, verification statuses, and the prohibited-claim-language pattern check at build time — not a claim of individual clinical review; see “Publisher / editorial identity” above for why no named reviewer is attributed yet.

Sourcing standard

Every study record carries five visible qualifiers: species/population; exposure, route and schedule; comparator and duration; endpoint and numeric result; and what the study did NOT establish. Every record carries a verification_status, and every trial/registry identifier a citation_status. Where an exact NCT/PMID/DOI was not confirmed against the primary record, it is marked needs_primary_fulltext rather than presented as verified — see the methodology page.

Monetization

Two intervention pages — Fisetin and Quercetin — carry an affiliate link. The link points to the compound the trials used. No sponsored placements, no ads.txt, no advertiser input of any kind. Prescription and investigational compounds are never linked. This is still a reference resource, not a shopping guide; see the affiliate disclosure for the rules that keep the link out of the evidence.

Prohibited claim language

The editorial process blocks a fixed list of prohibited phrases (e.g. claims of clearing all senescent cells, reversing cellular aging, or a proven human lifespan effect) via an automated pattern check run at build time. See generators/check_claim_patterns.py.

Licensing & data enquiries

The structured senescence evidence dataset behind this site is independently sourced. For dataset-licensing or research-data enquiries, use the form below. This form is an inbound enquiry channel only: submitting it does not buy coverage, placement, or a change to any record, and no sponsored placements or advertising appear anywhere on this site. Two intervention pages — Fisetin and Quercetin — carry an affiliate link.

Version history